Stay updated with breaking news from Temporary Recommendation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Kohima, May 8 (MExN): Nagaland, on May 8, registered for four new COVID-19 cases, an official update informed. The new cases were reported from Kohima, the Department of Health and Family Welfare informed on Twitter. On Monday, there were also two recove
Barely few months after President Mokgweetsi Masisi called western countries paternalistic over the decision to put travellers from Botswana on ban in the wake of outbreak of omicron COVID-19 variant, Botswana has responded with a similar policy.
by Tyler Durden Saturday, May 22, 2021 - 09:00 PM Last week, we reported that several increasingly desperate communities across India have been embracing a controversial (at least, in the US) strategy for trying to mitigate the fallout from the crisis. Communities have been doling out inexpensive anti-malaria drugs as a prophylactic against COVID-19, citing scant data showing it could help lower mortality and hospitalization rates - which is critical given India's nationwide shortage of hospital beds and oxygen to sustain seriously ill patients. The drug in question, ivermectin, is in some wa...
Existing affordable drugs could rapidly reduce Covid-19 cases and deaths in India May 11, 2021, 12:15 PM IST Vikas P. Sukhatme MD, ScD, is the Robert W. Woodruff Professor of Medicine, Dean of Emory University School of Medicine, and Chief Academic Officer of Emory Healthcare. He is the founding director of the Emory-based Morningside Center for Innovative and Affordable Medicine. You can reach him at vsukhatme@emory.edu Vidula Sukhatme, MS, is an adjunct instructor at Emory University’s Rollins School of Public Health and is the founding CEO of GlobalCures, a non-profit ...